Analyst Recommendations

Piper Sandler analyst issues NEUTRAL recommendation for PZZA on January 12, 2024 04:09PM ET. The previous analyst recommendation was Neutral.PZZA was trading at $71.89 at issue of the...

January 12, 2024   PZZA -0.33%

Susquehanna analyst issues UNDERPERFORM recommendation for MRVL on January 12, 2024 04:00PM ET. The previous analyst recommendation was Underperform.MRVL was trading at $65.68 at issue of the analyst...

January 12, 2024   MRVL -9.84%

UBS analyst issues BUY recommendation for MRVL on January 12, 2024 04:00PM ET. The previous analyst recommendation was Buy.MRVL was trading at $65.68 at issue of the analyst...

January 12, 2024   MRVL -9.84%

Oppenheimer analyst issues OUTPERFORM recommendation for NFLX on January 12, 2024 03:31PM ET. The previous analyst recommendation was Outperform.NFLX was trading at $492.12 at issue of the analyst...

January 12, 2024   NFLX 4.66%

Oppenheimer analyst issues BUY recommendation for NDAQ on January 12, 2024 03:00PM ET. The previous analyst recommendation was Buy.NDAQ was trading at $56.675 at issue of the analyst...

January 12, 2024   NDAQ 2.33%

RBC Capital analyst issues SECTOR PERFORM recommendation for MDT on January 12, 2024 03:01PM ET. The previous analyst recommendation was Sector Perform.MDT was trading at $87.315 at issue...

January 12, 2024   MDT 5.04%

UBS analyst issues BUY recommendation for SYK on January 12, 2024 03:00PM ET. The previous analyst recommendation was Buy.SYK was trading at $311.69 at issue of the analyst...

January 12, 2024   SYK 4.20%

Benchmark analyst issues BUY recommendation for KRUS on January 12, 2024 12:00PM ET. The previous analyst recommendation was Buy.KRUS was trading at $90.01 at issue of the analyst...

January 12, 2024   KRUS -0.71%

Goldman Sachs analyst issues SELL recommendation for HP on January 12, 2024 12:00PM ET. The previous analyst recommendation was Sell.HP was trading at $33.51 at issue of the...

January 12, 2024   HP 1.23%

RBC Capital analyst issues BUY recommendation for MRNA on January 12, 2024 12:00PM ET. The previous analyst recommendation was Buy.MRNA was trading at $107.0993 at issue of the...

January 12, 2024   MRNA 10.01%